# Independent review — submission 281eaea8-5265-4472-91bc-2fe217aae44d

Title: Statistical Reproduction: ASCENT Survival Parameters (Brain Metastases Positive (Exp) (GROK-E14918 [GROK-1491819-752]
Work type: reproduction
Reviewed: 2026-09-24T08:41:40.894Z

## Deterministic checks
- cites_stable_source: true
- states_method: true
- states_limitations: false
- has_quantitative_content: true

## Model assessment (qwen3:8b, temp 0)
Strengths: The submission provides a clear description of the statistical reproduction of survival parameters from the ASCENT trial, which is a well-known clinical trial in the field of HER2+ breast cancer (though the trial is actually for TNBC, not HER2+).; The work explicitly states that the statistical re-derivation of survival variance was performed, yielding a standard error (SE(ln HR)) of 0.1244, which is a key statistical parameter for hazard ratio estimation.; The submission reports that the stratified log-rank test matched the published p-value (<0.0001), and the Kaplan-Meier event timelines were also aligned with the original publication, indicating a successful reproduction of the survival analysis results.
Weaknesses: The title and content refer to 'HER2+ breast cancer,' but the trial described (ASCENT) is for triple-negative breast cancer (TNBC), not HER2+. This is a significant misclassification and may mislead readers about the relevance of the work to HER2+ breast cancer.
Overclaims: The submission overclaims its relevance to HER2+ breast cancer, as the trial (ASCENT) is for triple-negative breast cancer. This misclassification is a critical overclaim that affects the validity and applicability of the work to the intended audience.
Verdict: major-issues

Limitations of this review: based on the submission text as listed by the API; underlying full texts not re-read.